A monoclonal cytolytic T-lymphocyte response observed in a melanoma patient vaccinated with a tumor-specific antigenic peptide encoded by gene MAGE-3.
about
The response of autologous T cells to a human melanoma is dominated by mutated neoantigensA novel diffuse large B-cell lymphoma-associated cancer testis antigen encoding a PAS domain proteinBiological response modifiers in cancerT cell responses against tumor associated antigens and prognosis in colorectal cancer patientsDiversity and recognition efficiency of T cell responses to cancerVaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trialT-cell clonotypes in cancerProgress and controversies in developing cancer vaccines.Cancer/testis antigens: an expanding family of targets for cancer immunotherapyEvaluation of the sentinel immunized node for immune monitoring of cancer vaccinesData analysis as a source of variability of the HLA-peptide multimer assay: from manual gating to automated recognition of cell clusters.Dendritic cell-derived exosomes promote natural killer cell activation and proliferation: a role for NKG2D ligands and IL-15Ralpha.Melanoma cells treated with GGTI and IFN-gamma allow murine vaccination and enhance cytotoxic response against human melanoma cells.Cytolytic T-cell response against Epstein-Barr virus in lung cancer patients and healthy subjects.Prolonged survival of patients with lung adenocarcinoma expressing XAGE-1b and HLA class I antigensFunctional HY-specific CD8+ T cells are found in a high proportion of women following pregnancy with a male fetus.Modulating T-cell immunity to tumours: new strategies for monitoring T-cell responses.Cytolytic T-cell responses of cancer patients vaccinated with a MAGE antigen.Tumor-specific shared antigenic peptides recognized by human T cells.Towards patient-specific tumor antigen selection for vaccination.Prospects for immunotherapy of malignant disease.Principles of tumor immunosurveillance and implications for immunotherapy.Antigen-specific immunotherapy and cancer vaccines.Immunohistochemistry in melanocytic proliferative lesions.No evidence for circulating HuD-specific CD8+ T cells in patients with paraneoplastic neurological syndromes and Hu antibodies.Identification of immunogenic MAGED4B peptides for vaccine development in oral cancer immunotherapyImmunological monitoring of cancer vaccine therapy.High frequency of antitumor T cells in the blood of melanoma patients before and after vaccination with tumor antigens.Locoregional immunotherapy of malignant effusion from colorectal cancer using the streptococcal preparation OK-432 plus interleukin-2: induction of autologous tumor-reactive CD4+ Th1 killer lymphocytes.A review of vaccine clinical trials for non-small cell lung cancer.MAGE-A8 overexpression in transitional cell carcinoma of the bladder: identification of two tumour-associated antigen peptidesAn overview of the GAGE cancer/testis antigen family with the inclusion of newly identified members.Immune suppression in tumors as a surmountable obstacle to clinical efficacy of cancer vaccinesImmunotherapy of distant metastatic disease.Self-antigen-specific CD8+ T cell precursor frequency determines the quality of the antitumor immune response.Bioinformatics construction of the human cell surfaceome.Diversity of escape variant mutations in Simian virus 40 large tumor antigen (SV40 Tag) epitopes selected by cytotoxic T lymphocyte (CTL) clones.Correlation between tumor regression and T cell responses in melanoma patients vaccinated with a MAGE antigen.Current vaccine updates for lung cancer.Molecular profiling of melanoma and the evolution of patient-specific therapy.
P2860
Q24535034-24B752D4-53E3-415A-B563-046651D5BDB2Q24648046-DB01D9A9-6280-4687-84BB-68757BFF7C11Q24685049-AB22BA72-70F9-4D72-9E6F-81563E1068A0Q24796257-77785A26-1495-49FA-900B-901886DB08E4Q24796652-AE316094-DEC2-4EB1-94A1-00290A1A7BA0Q24801506-45615A92-7B9E-4D17-9E35-9EFA738DE574Q24803891-D26AD7E6-6F09-41D4-95FD-B0851A74BA3FQ24810256-E4A25420-2A8C-4107-B4F6-B9A87782265DQ28215652-56651115-B26C-4495-961D-2F514C76BB13Q30433911-615F1F85-2E96-4915-974B-AE4FB5D48375Q30927297-0A91CDF9-213C-4A4C-B253-CE14C2036EF6Q33421740-A34F61E2-5D2D-431E-8306-83BE586046BCQ33530146-DFCBE040-35AC-44EC-B1B4-2AEFDD0FD449Q34010871-CF642BAA-855F-4CF5-85C2-BD53EEB14C54Q34111868-085C227A-EE67-4F5A-B765-7026A22FE451Q34567523-6937CB7F-33D1-4B58-AA43-D53C60401C2CQ34791108-1637360B-5DDA-457F-976D-64720E0713AFQ35005912-5BF66460-74D6-4831-B5B7-E36074C9DFD5Q35005926-AA475C27-61B8-499A-BCC1-B453858C7881Q35005960-1E0C14FA-27D9-463D-A4D0-E2701510E517Q35041705-D6AC3A4E-8CF2-41B2-9C89-55DC1E0B7D61Q35043113-A0E34D92-C405-4241-8F4D-49C78F89DCFCQ35199473-6EA63873-2875-4EEA-95A8-9EA0853F2981Q35798186-2896F330-9401-45B0-943E-D64793E0A253Q35880899-C789E7A1-FE62-452B-8F12-1D00C5B3943BQ35896241-B37A86B7-A41B-4732-A25B-A3A5B02EA1DBQ35907052-6CFBD9BC-7A27-4CD8-AC4C-2E68D23D018AQ36402611-61FF49A9-2824-42C0-A1A7-0BA3E9DAD73DQ36671598-B3ED02D3-4CC4-43A6-86B1-2DCE5096E934Q36675454-CC6CB491-D2E8-4643-A173-13EC0B7A2F0EQ36695328-2F8DC1FF-E653-4695-8E90-AA5914814ABCQ37052200-52D252FF-50A8-4ECC-9F93-B00AB308B8F6Q37137360-FB177A43-B5CB-4BD2-B809-7F53A1911187Q37266668-201D0B9B-5956-4FAE-AB2C-3E8FBF00A252Q37273315-22848A3B-52AE-4893-9C98-7F34923E354AQ37377413-228D9780-12B6-4FCB-8D78-695DE64A869DQ37400231-C8D96DF6-653A-473E-A2B6-85517C5FC283Q37570169-D350F668-9BB8-4BD2-B5B2-50930712AFDAQ37706593-D8A95148-E0E7-408F-9DC2-F953F4FD03D9Q37855229-23A85210-A331-44CE-801A-37DEBE5FDE95
P2860
A monoclonal cytolytic T-lymphocyte response observed in a melanoma patient vaccinated with a tumor-specific antigenic peptide encoded by gene MAGE-3.
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
A monoclonal cytolytic T-lymph ...... eptide encoded by gene MAGE-3.
@ast
A monoclonal cytolytic T-lymph ...... eptide encoded by gene MAGE-3.
@en
type
label
A monoclonal cytolytic T-lymph ...... eptide encoded by gene MAGE-3.
@ast
A monoclonal cytolytic T-lymph ...... eptide encoded by gene MAGE-3.
@en
prefLabel
A monoclonal cytolytic T-lymph ...... eptide encoded by gene MAGE-3.
@ast
A monoclonal cytolytic T-lymph ...... eptide encoded by gene MAGE-3.
@en
P2093
P2860
P356
P1476
A monoclonal cytolytic T-lymph ...... eptide encoded by gene MAGE-3.
@en
P2093
M Marchand
P G Coulie
V Brichard
V Karanikas
P2860
P304
10290-10295
P356
10.1073/PNAS.161260098
P407
P577
2001-08-21T00:00:00Z